Tyra Biosciences (TYRA) Competitors $14.00 -0.50 (-3.45%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TYRA vs. MRUS, ACAD, TWST, MOR, VCEL, SWTX, ZLAB, KYMR, GMTX, and VERAShould you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include Merus (MRUS), ACADIA Pharmaceuticals (ACAD), Twist Bioscience (TWST), MorphoSys (MOR), Vericel (VCEL), SpringWorks Therapeutics (SWTX), Zai Lab (ZLAB), Kymera Therapeutics (KYMR), Gemini Therapeutics (GMTX), and Vera Therapeutics (VERA). These companies are all part of the "pharmaceutical products" industry. Tyra Biosciences vs. Merus ACADIA Pharmaceuticals Twist Bioscience MorphoSys Vericel SpringWorks Therapeutics Zai Lab Kymera Therapeutics Gemini Therapeutics Vera Therapeutics Tyra Biosciences (NASDAQ:TYRA) and Merus (NASDAQ:MRUS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends. Do insiders & institutionals have more ownership in TYRA or MRUS? 84.1% of Tyra Biosciences shares are held by institutional investors. Comparatively, 96.1% of Merus shares are held by institutional investors. 15.4% of Tyra Biosciences shares are held by insiders. Comparatively, 4.6% of Merus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to TYRA or MRUS? In the previous week, Merus had 8 more articles in the media than Tyra Biosciences. MarketBeat recorded 9 mentions for Merus and 1 mentions for Tyra Biosciences. Tyra Biosciences' average media sentiment score of 0.50 beat Merus' score of 0.49 indicating that Tyra Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merus 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community favor TYRA or MRUS? Merus received 322 more outperform votes than Tyra Biosciences when rated by MarketBeat users. However, 73.81% of users gave Tyra Biosciences an outperform vote while only 67.11% of users gave Merus an outperform vote. CompanyUnderperformOutperformTyra BiosciencesOutperform Votes3173.81% Underperform Votes1126.19% MerusOutperform Votes35367.11% Underperform Votes17332.89% Is TYRA or MRUS more profitable? Tyra Biosciences has a net margin of 0.00% compared to Merus' net margin of -680.61%. Tyra Biosciences' return on equity of -24.56% beat Merus' return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -24.56% -23.31% Merus -680.61%-38.89%-31.16% Which has stronger earnings & valuation, TYRA or MRUS? Tyra Biosciences has higher earnings, but lower revenue than Merus. Merus is trading at a lower price-to-earnings ratio than Tyra Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$69.13M-$1.61-8.70Merus$43.95M65.19-$154.94M-$3.95-10.59 Do analysts prefer TYRA or MRUS? Tyra Biosciences currently has a consensus price target of $31.00, suggesting a potential upside of 121.43%. Merus has a consensus price target of $85.64, suggesting a potential upside of 104.63%. Given Tyra Biosciences' higher probable upside, equities research analysts plainly believe Tyra Biosciences is more favorable than Merus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Merus 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 3.14 Which has more risk & volatility, TYRA or MRUS? Tyra Biosciences has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, Merus has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. SummaryTyra Biosciences beats Merus on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TYRA vs. The Competition Export to ExcelMetricTyra BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$708.44M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-8.7010.5991.3417.19Price / SalesN/A195.381,116.63116.80Price / CashN/A57.1642.5837.86Price / Book2.955.104.794.78Net Income-$69.13M$151.51M$120.07M$225.60M7 Day Performance-6.29%-2.14%-1.90%-1.24%1 Month Performance-8.85%-3.13%11.43%3.06%1 Year Performance2.34%11.51%30.59%16.50% Tyra Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TYRATyra Biosciences2.0677 of 5 stars$14.00-3.4%$31.00+121.4%+2.0%$708.44MN/A-8.7020Positive NewsHigh Trading VolumeMRUSMerus2.8134 of 5 stars$42.83flat$85.64+99.9%+61.7%$2.93B$43.95M-10.8437ACADACADIA Pharmaceuticals3.8511 of 5 stars$17.44+1.0%$25.60+46.8%-41.9%$2.90B$726.44M22.13510TWSTTwist Bioscience2.5589 of 5 stars$48.87+2.9%$51.90+6.2%+36.7%$2.90B$312.97M-13.19990MORMorphoSys0.128 of 5 stars$18.96+2.4%$14.33-24.4%N/A$2.86B$238.28M-5.45730News CoverageVCELVericel1.4466 of 5 stars$57.54+0.1%$59.71+3.8%+66.0%$2.84B$226.84M957.83300Analyst ForecastSWTXSpringWorks Therapeutics2.0141 of 5 stars$38.16-0.4%$69.50+82.1%+11.3%$2.84B$5.45M-9.87305ZLABZai Lab1.7111 of 5 stars$26.03-1.1%$55.00+111.3%-7.4%$2.83B$355.75M-9.512,175KYMRKymera Therapeutics2.266 of 5 stars$43.54+3.3%$53.88+23.8%+66.0%$2.82B$87.56M-18.00170Positive NewsGMTXGemini TherapeuticsN/A$64.89+1.0%N/A+10.4%$2.81BN/A-64.8930VERAVera Therapeutics3.4798 of 5 stars$44.33+0.6%$59.22+33.6%+180.4%$2.81BN/A-16.8840Insider Trade Related Companies and Tools Related Companies MRUS Alternatives ACAD Alternatives TWST Alternatives MOR Alternatives VCEL Alternatives SWTX Alternatives ZLAB Alternatives KYMR Alternatives GMTX Alternatives VERA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TYRA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TYRA Stock Alerts